These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27726426)

  • 1. No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder.
    Vo LC; Snyder C; McCracken C; McDougle CJ; McCracken JT; Aman MG; Tierney E; Arnold LE; Levi D; Kelleman M; Carroll D; Morrissey J; Vitiello B; Scahill L
    J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):900-908. PubMed ID: 27726426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial.
    DeVane CL; Charles JM; Abramson RK; Williams JE; Carpenter LA; Raven S; Gwynette F; Stuck CA; Geesey ME; Bradley C; Donovan JL; Hall AG; Sherk ST; Powers NR; Spratt E; Kinsman A; Kruesi MJ; Bragg JE
    Pharmacotherapy; 2019 Jun; 39(6):626-635. PubMed ID: 31063671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone Combination Therapy With Propentofylline for Treatment of Irritability in Autism Spectrum Disorders: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Behmanesh H; Moghaddam HS; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2019; 42(6):189-196. PubMed ID: 31725473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone in children with autism and serious behavioral problems.
    McCracken JT; McGough J; Shah B; Cronin P; Hong D; Aman MG; Arnold LE; Lindsay R; Nash P; Hollway J; McDougle CJ; Posey D; Swiezy N; Kohn A; Scahill L; Martin A; Koenig K; Volkmar F; Carroll D; Lancor A; Tierney E; Ghuman J; Gonzalez NM; Grados M; Vitiello B; Ritz L; Davies M; Robinson J; McMahon D;
    N Engl J Med; 2002 Aug; 347(5):314-21. PubMed ID: 12151468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Pregnenolone Adjunct to Risperidone Ameliorate Irritable Behavior in Adolescents With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial?
    Ayatollahi A; Bagheri S; Ashraf-Ganjouei A; Moradi K; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2020; 43(5):139-145. PubMed ID: 32947424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
    Aman M; Rettiganti M; Nagaraja HN; Hollway JA; McCracken J; McDougle CJ; Tierney E; Scahill L; Arnold LE; Hellings J; Posey DJ; Swiezy NB; Ghuman J; Grados M; Shah B; Vitiello B
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):482-93. PubMed ID: 26262903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Hajizadeh-Zaker R; Ghajar A; Mesgarpour B; Afarideh M; Mohammadi MR; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):74-81. PubMed ID: 29027815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled clinical trial.
    Momtazmanesh S; Amirimoghaddam-Yazdi Z; Moghaddam HS; Mohammadi MR; Akhondzadeh S
    Psychiatry Clin Neurosci; 2020 Jul; 74(7):398-405. PubMed ID: 32347624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.
    Ghanizadeh A; Moghimi-Sarani E
    BMC Psychiatry; 2013 Jul; 13():196. PubMed ID: 23886027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder.
    Scahill L; Jeon S; Boorin SJ; McDougle CJ; Aman MG; Dziura J; McCracken JT; Caprio S; Arnold LE; Nicol G; Deng Y; Challa SA; Vitiello B
    J Am Acad Child Adolesc Psychiatry; 2016 May; 55(5):415-23. PubMed ID: 27126856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial.
    Hendouei F; Sanjari Moghaddam H; Mohammadi MR; Taslimi N; Rezaei F; Akhondzadeh S
    J Clin Pharm Ther; 2020 Apr; 45(2):324-334. PubMed ID: 31714621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. l -carnitine adjunct to risperidone for treatment of autism spectrum disorder-associated behaviors: a randomized, double-blind clinical trial.
    Nasiri M; Parmoon Z; Farahmand Y; Moradi A; Farahmand K; Moradi K; Basti FA; Mohammadi MR; Akhondzadeh S
    Int Clin Psychopharmacol; 2024 Jul; 39(4):232-239. PubMed ID: 37551601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
    Asadabadi M; Mohammadi MR; Ghanizadeh A; Modabbernia A; Ashrafi M; Hassanzadeh E; Forghani S; Akhondzadeh S
    Psychopharmacology (Berl); 2013 Jan; 225(1):51-9. PubMed ID: 22782459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of the modified Children's Yale-Brown Obsessive Compulsive Scale to detect change: Results from two multi-site trials.
    Scahill L; Sukhodolsky DG; Anderberg E; Dimitropoulos A; Dziura J; Aman MG; McCracken J; Tierney E; Hallett V; Katz K; Vitiello B; McDougle C
    Autism; 2016 Feb; 20(2):145-52. PubMed ID: 25882391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial severity and efficacy of risperidone in autism: Results from the RUPP trial.
    Levine SZ; Kodesh A; Goldberg Y; Reichenberg A; Furukawa TA; Kolevzon A; Leucht S
    Eur Psychiatry; 2016 Feb; 32():16-20. PubMed ID: 26802979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of Change in Corrected QT Interval in Children and Adolescents Receiving Antipsychotic Treatment: A 12 Month Study.
    Alda JA; Muñoz-Samons D; Tor J; Merchán-Naranjo J; Tapia-Casellas C; Baeza I; Calvo-Escalona R; Castro-Fornieles J; Martínez-Cantarero C; Andrés-Nestares P; Fernández-Avilés F; Arango C
    J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):449-57. PubMed ID: 26779966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednisolone as Adjunctive Treatment to Risperidone in Children With Regressive Type of Autism Spectrum Disorder: A Randomized, Placebo-Controlled Trial.
    Malek M; Ashraf-Ganjouei A; Moradi K; Bagheri S; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2020; 43(2):39-45. PubMed ID: 32168067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.
    Troost PW; Lahuis BE; Steenhuis MP; Ketelaars CE; Buitelaar JK; van Engeland H; Scahill L; Minderaa RB; Hoekstra PJ
    J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1137-44. PubMed ID: 16239862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.